In this study, with the help of the TLR7/8 agonist-conjugated radiosensitive peptide hydrogel, tumor-promoting and radio-resistant M2 macrophages were reprogrammed into M1 macrophages through macrophage polarization (Figure 6A) [98,99]. The gene discussed is TLR7; the disease is neoplasm.